ImmunologybioRxivPreprint
Statistical Methodology for Qualification of a Non-Clinical Risk Assessment Peptide:T Cell Proliferation Assay to Support Decision Making
Sophie Tourdot, Zhiping You, Andrew Ciarla…·Gregory S. Steeno
The paper develops a statistical framework to validate a T cell proliferation assay for immunogenicity risk assessment in biologics development.
DOI 10.64898/2026.06.03.729894